Emani, S.; Vangala, A.; Buonocore, F.; Yarandi, N.; Calabrese, G.
Chitosan Hydrogels Cross-Linked with Trimesic Acid for the Delivery of 5-Fluorouracil in Cancer Therapy. Pharmaceutics 2023, 15, 1084.
https://doi.org/10.3390/pharmaceutics15041084
AMA Style
Emani S, Vangala A, Buonocore F, Yarandi N, Calabrese G.
Chitosan Hydrogels Cross-Linked with Trimesic Acid for the Delivery of 5-Fluorouracil in Cancer Therapy. Pharmaceutics. 2023; 15(4):1084.
https://doi.org/10.3390/pharmaceutics15041084
Chicago/Turabian Style
Emani, Sravani, Anil Vangala, Federico Buonocore, Niousha Yarandi, and Gianpiero Calabrese.
2023. "Chitosan Hydrogels Cross-Linked with Trimesic Acid for the Delivery of 5-Fluorouracil in Cancer Therapy" Pharmaceutics 15, no. 4: 1084.
https://doi.org/10.3390/pharmaceutics15041084
APA Style
Emani, S., Vangala, A., Buonocore, F., Yarandi, N., & Calabrese, G.
(2023). Chitosan Hydrogels Cross-Linked with Trimesic Acid for the Delivery of 5-Fluorouracil in Cancer Therapy. Pharmaceutics, 15(4), 1084.
https://doi.org/10.3390/pharmaceutics15041084